HSBC/CALL/AMGEN/400/0.1/16.01.26 | Market Closed - BOERSE MUENCHEN 01:06:33 06/07/2024 am IST | ||
| 1.47 EUR | +2.08% |
|
| Current month | -6.96% | ||
| 1 month | -9.82% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 05/24/05 | 1.47 | +2.08% |
| 04/24/04 | 1.44 | -1.37% |
| 03/24/03 | 1.46 | -2.67% |
| 02/24/02 | 1.5 | -3.23% |
| 01/24/01 | 1.55 | -1.90% |
Real-time BOERSE MUENCHEN
Last update July 06, 2024 at 01:06 am IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | HSBC |
| WKN | HS2FUT |
| ISIN | DE000HS2FUT3 |
| Date issued | 28/09/2023 |
| Strike | 400 $ |
| Maturity | 16/01/2026 (558 Days) |
| Parity | 10 : 1 |
| Emission price | 1.17 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.3 € |
|---|---|
| Lowest since issue | 0.68 € |
| Delta | 0.29x |
| Omega | 5.707 |
| Premium | 33.79x |
| Gearing | 19.51x |
| Moneyness | 0.7772 |
| Difference Strike | 89.12 $ |
| Difference Strike % | +22.28% |
| Spread | 0.02 € |
| Spread % | 1.35% |
| Theoretical value | 1.470 |
| Implied Volatility | 26.00 % |
| Total Loss Probability | 79.78 % |
| Intrinsic value | 0.000000 |
| Present value | 1.470 |
| Break even | 415.93 € |
| Theta | -0.02x |
| Vega | 0.12x |
| Rho | 0.1x |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.9
USD
Average target price
316.4
USD
Spread / Average Target
+1.79%
- Stock Market
- Warrants
- Warrant
